12:00 AM
 | 
Mar 15, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Hycor regulatory update

HYBD received U.S. Patent No. 5,863,799 covering its Erythrocyte Sedimentation Rate...

Read the full 34 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >